Croton-on-the-Hudson, NY, United States of America

Xiaojing Zheng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaojing Zheng: Innovator in Protein Measurement Technologies

Introduction

Xiaojing Zheng is a prominent inventor based in Croton-on-the-Hudson, NY (US). She has made significant contributions to the field of protein measurement, particularly in the area of post-translational modifications. Her innovative approach has the potential to enhance the accuracy of protein quantification, which is crucial in various biotechnological applications.

Latest Patents

Xiaojing Zheng holds a patent titled "Heavy peptide approach to accurately measure unprocessed C-terminal lysine." This patent provides a method for accurately measuring post-translational modifications in proteins, such as antibodies. The method utilizes heavy isotopic standards to generate a calibration curve, allowing for precise quantitation of modified peptides. This technique is particularly useful for quantifying C-terminal truncation in antibodies using mass spectrometry.

Career Highlights

Xiaojing Zheng is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in protein measurement technologies. Her work is instrumental in developing methods that improve the reliability of protein analysis, which is vital for therapeutic development and quality control in biopharmaceuticals.

Collaborations

Some of her notable coworkers include Tyler Greer and Milos Cejkov. Their collaborative efforts contribute to the innovative environment at Regeneron Pharmaceuticals, fostering advancements in biotechnological research.

Conclusion

Xiaojing Zheng's contributions to the field of protein measurement exemplify the impact of innovative thinking in biotechnology. Her patented methods enhance the accuracy of protein analysis, paving the way for advancements in therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…